Checkmate plucks BMS exec Bash to be new CEO
Checkmate plucks BMS exec Bash to be new CEO mbayer [...]
Rivus throws down mid-stage liver fat data on quest to climb NASH mountain
Rivus throws down mid-stage liver fat data on quest to [...]
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic
Chasing Novartis and Roche, Ventus banks $140M to take inflammatory [...]
Axsome’s migraine drug finally slated for FDA inspection but investors really want to know about stalled depression therapy
Axsome’s migraine drug finally slated for FDA inspection but investors [...]
Ovid pens deal to offload twice-failed former lead program, positioning Healx to write new chapter in fragile X
Ovid pens deal to offload twice-failed former lead program, positioning [...]
Pfizer, in a rare COVID-19 setback, dumps Paxlovid’s intravenous sibling to leave ACTIV-3 future in doubt
Pfizer, in a rare COVID-19 setback, dumps Paxlovid’s intravenous sibling [...]
CVS to bring late-stage clinical trials to certain locations in push to serve underrepresented patients
CVS to bring late-stage clinical trials to certain locations in [...]
Boundless Bio lures Berkley from Ionis to support clinical push
Boundless Bio lures Berkley from Ionis to support clinical push [...]
CANbridge, targeting gaps in AstraZeneca’s rare disease coverage, posts early-phase data on C5 inhibitor
CANbridge, targeting gaps in AstraZeneca’s rare disease coverage, posts early-phase [...]
Bayer ends work on cough med that passed phase 2b weeks after FDA rejected Merck’s drug
Bayer ends work on cough med that passed phase 2b [...]